Australian Society for Biochemistry and Molecular Biology Conference

1-3 October 2019, Fremantle Esplanade Hotel, Perth, Western Australia

Key Dates

Conference Dates: 01-03 October 2019
Abstracts Open: 29 January 2019
Registrations Open: 1 April 2019
Abstract Close: 2 April 2019
Early Bird Registration Deadline: 1 July 2019

Express Your Interest

More Information Coming Soon
Join our mailing list to be kept up to date with information on the Conference.

Western Australia

WA has many great attractions that will provide countless hours of leisure and fun. There’s a lot to see and do, including beautiful beaches and natural park lands all whilst enjoying an average of 8 hours of sunshine a day.

Click here and see what Western Australia has to offer.



to ASBMB 2019 in Perth!

It’s an exciting time for Australian Society of Biochemistry and Molecular Biology (ASBMB) as we continue to grow and change. ASBMB2019 is the first “new” biannual meeting of the ASBMB that will be interspersed with future biannual ComBio meetings. ASBMB2019 will be held at the Fremantle Esplanade Hotel in Perth’s port city of Fremantle, which is within walking distance of a range restaurants, breweries, hotels and apartments.

The 3-day program (Tuesday 1st October – Thursday 3rd October 2019) will feature a number of overseas plenary presentations, society speciality lectures, poster sessions, 3-minute poster presentations and an E/MCR mini-symposium are also planned. The scientific program of the conference will include the themes:

  • Gene Editing
  • RNA Biology
  • Drug Discovery

Confirmed plenary speakers include Lingling Chen and Tom Blundell.

Lingling Chen is a molecular and RNA biologist from the Shanghai Institute of Biochemistry and Cell Biology (CAS), China. She developed methods for the genome-wide discovery and characterization of nonpolyadenylated RNAs, which led to the identification of sno-processed lncRNAs and circular RNAs. She also showed that some sno-processed lncRNAs are conspicuously absent in people with the neurodevelopmental genetic disorder Prader-Willi Syndrome (PWS).

Tom Blundell is a biochemist and structural biologist from the University of Cambridge in the UK. He was a member of the team that solved the first structure of a protein hormone, insulin and has since made contributions to structural biology of polypeptide hormones, growth factors, receptor activation, signal transduction and DNA double-strand break repair. He has been involved in drug discovery with many drugs moved to clinical trials. He has developed software for protein modelling and understanding the effects of mutations on protein function, leading to new approaches to structure-guided and fragment-based lead discovery.

One of the missions of the ASBMB is to increase diversity and inclusion in our scientific community. We have a zero tolerance for harassment of any kind and we hope to lead our society into the future as a more inclusive and diverse community. Share openly, be respectful, form new collaborations and enjoy beautiful Perth!

Warmest Regards,

Nic Taylor
Chair ASBMB 2019
on behalf of the ASBMB 2019 Executive Committee


Express Your Interest

Join our mailing list to be kept up to date with information on the Conference.